Login / Signup

Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient.

Luke M LewisAlice L TangTrisha M Wise-DraperKasiani C MyersJoel S GreenbergerVinita Takiar
Published in: Head & neck (2020)
The FA patient population has a clear need for adjuvant treatment regimens given their predilection for HNSCC. A therapeutic trial may allow FA and other radiosensitive patients to trial radiation with the option to terminate treatment before any severe side effects occur and for some to complete a full course of treatment.
Keyphrases
  • clinical trial
  • study protocol
  • early stage
  • end stage renal disease
  • chronic kidney disease
  • phase iii
  • patients undergoing
  • squamous cell carcinoma
  • early onset
  • peritoneal dialysis
  • patient reported outcomes